Panuveitis is a serious inflammation inside the eye. It affects both the front and back parts of the eye, which can lead to vision loss. It can be caused by infections, autoimmune diseases, or other conditions.
Every report comes from a Lived member, sent anonymously.
Have you tried Humira (Adalimumab) for Panuveitis?
Panuveitis is inflammation that affects the whole uvea, the middle layer of the eye that runs from the front to the back. The uvea includes the iris (the colored part of the eye), the ciliary body behind it, and the choroid, a layer of blood vessels that supports the retina. Uveitis is the general term for inflammation in this layer; panuveitis is the form in which all of it is involved rather than only the front or back. People may notice blurry vision, floaters (dark spots or threads drifting across their sight), eye pain, redness and sensitivity to light. It can affect one eye or both. Because inflammation reaches the retina and other structures at the back of the eye, panuveitis is often more serious than inflammation limited to the front, and without treatment it can cause lasting vision loss.
Panuveitis is a pattern of inflammation rather than a single disease, and finding what is driving it matters because treatment depends on the cause. Sometimes no cause is found. Some cases come from the immune system attacking the eye, often as part of a wider inflammatory disease. Examples include sarcoidosis, Behcet's disease and Vogt-Koyanagi-Harada (VKH) disease, a condition that can also affect the skin, hearing and nervous system. Other cases are caused by infections that reach the eye, such as syphilis, tuberculosis or toxoplasmosis (a parasite infection). Less often, a cancer such as lymphoma can cause inflammation that looks like uveitis. Uveitis is most common between ages 20 and 60, and smoking raises the risk. Some causes, such as VKH disease, are more common in particular populations, including people of Asian, Latino and Middle Eastern descent.
An eye doctor diagnoses panuveitis with a dilated eye exam, using drops to widen the pupil so the inside of the eye, including the retina and the layers behind it, can be examined. Finding inflammation at the front, middle and back of the eye is what distinguishes panuveitis from narrower forms of uveitis. The next step is looking for a cause. The doctor will ask about other symptoms, such as joint pain, rashes, mouth sores, breathing problems or hearing changes, and may order blood tests, a chest X-ray or other imaging. Testing for infections such as syphilis and tuberculosis is especially important, because the treatments used to calm immune-driven inflammation can make an untreated infection worse. Care is often shared with a uveitis specialist, and with a rheumatologist when a body-wide disease is involved.
Treatment aims to stop the inflammation quickly enough to protect vision, then keep it from returning. When an infection is responsible, treating that infection is central to care, with anti-inflammatory treatment used alongside it as needed. For panuveitis that is not caused by infection, corticosteroids (steroids) are usually the first step. They can be given as eye drops, pills, injections in or around the eye, or a small implant placed in the eye that releases medicine over months to years. Steroids work well, but they can cause cataracts (clouding of the lens) and glaucoma (raised pressure that can damage the optic nerve), and long courses of steroid pills have effects across the body. A long-term study found that an eye implant and whole-body treatment led to similarly good vision over about four and a half years; the implant controlled inflammation more reliably but caused more cataracts and glaucoma. Because panuveitis is often long-lasting, many people move on to steroid-sparing medicines that calm the immune system so the steroid dose can be lowered. Methotrexate and mycophenolate are common choices; studies comparing them are small, and methotrexate may control inflammation slightly better. Adalimumab (Humira, also sold as several biosimilar versions) is an injected biologic that blocks tumor necrosis factor (TNF), a signal that drives inflammation, and is approved for non-infectious panuveitis in adults and children 2 and older. In a major trial it roughly halved the risk of a flare or vision decline compared with placebo. Its main trade-off is a higher risk of serious infections, so people are tested for tuberculosis before and during treatment.
The course of panuveitis varies widely with its cause. Some people have a single episode that settles with treatment, while others have a chronic condition that flares and quiets over years. Many people with good care keep useful vision, but outcomes depend on how quickly inflammation is controlled and on the underlying disease. Treatment usually means frequent eye appointments at first, then regular follow-up for as long as the condition or its medicines need monitoring. Visits check whether inflammation is controlled and look for complications of both the disease and its treatment, including cataracts and raised eye pressure. Immune-suppressing medicines also come with their own monitoring. Steroid doses are usually lowered gradually rather than stopped at once, and flares can occur as treatment changes, so it helps to know what an early flare feels like for you. When a body-wide disease such as sarcoidosis or Behcet's is involved, managing it with other specialists is part of protecting the eyes.
See an eye doctor right away, the same day if possible, for new blurry vision, floaters, eye pain, eye redness or light sensitivity, because untreated inflammation can cause permanent vision loss. If you already have panuveitis, contact your eye care team promptly when these symptoms return or worsen, or when vision drops. If you take adalimumab, methotrexate, mycophenolate or steroid pills, contact your care team promptly about fever or other signs of infection, since these medicines weaken the body's defenses.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Panuveitis is like, what's helped you, or ask the community a question.